MENU
SNTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Senti Biosciences (SNTI) Ownership - Who owns Senti Biosciences?
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases... Show more
Profile
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
81.11M
P/E Ratio
8.41
Total Cash
33.8M
Projected Growth
N/A
Total Debt
32.45M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNTI
Capitalization
81.1M
P/E Ratio
8.41
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
33.8M
Total Cash/Share
1.30
Total Debt
32.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
37.9M
P/B Ratio
2.14
Cash Flow
N/A
Earnings
0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
4.22
Current Revenue Per Employee
2090.16
Dividends Per Share - Security
N/A
EBITDA
-54.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-59.25
Shares Held By Institutions
2.6M
Shares Outstanding - Current
26.1M
Total Liabilities
44.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-10.541
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com